11/20/2026 | Press release | Distributed by Public on 11/20/2026 05:05
|
FORM 4
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|
|||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) | ||
|
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) |
4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Performance Stock Unit (PSU) | $ 0 | 11/16/2026 | A | 243,309 | (2)(3) | (2)(3) | Ordinary Shares | 243,309 | $ 0 | 243,309 | D | ||||
| Reporting Owner Name / Address | Relationships | |||
| Director | 10% Owner | Officer | Other | |
|
Akkerman Michael 6 EAST 32ND ST. NEW YORK, NY 10016 |
CEO | |||
| /s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact | 11/20/2026 | |
| **Signature of Reporting Person | Date |
| * | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
| ** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
| (1) | The Reporting Person was granted 364,964 restricted stock units ("RSUs"), which each represent a contingent right to receive one ordinary share of Similarweb Ltd (the "Company"). 50% of the RSUs vest on November 2, 2027, and the remaining 50% of the RSUs vest in equal quarterly installments over the subsequent two (2) years beginning on the 15 month anniversary of the grant date, with the final vesting date on November 16, 2029, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. Full acceleration applies upon a termination without cause within 12 months following a Merger/Sale. |
| (2) | The performance stock units represent a contingent right to receive the company's ordinary shares upon the achievement of specified share price milestones. The reported amount is the on-target number of units (243,309); the number of units that may vest ranges from 0% to 200% of target (up to 486,618). |
| (3) | The units vest upon achievement of 60-day average closing share price milestones of $15.00 (50% of target), $20.00 (100%), $25.00 (150%) and $30.00 (200%), measured during the four-year period beginning 11/16/2026, subject to the Reporting Person's continued service through the applicable vesting date. Full acceleration applies upon a termination without cause within 12 months following a Merger/Sale. The shares reported in Table II represent performance stock units that have not yet vested. |
|
Remarks: This Form 4/A amends the Form 4 originally filed on November 18, 2026 (Accession number: 0001976408-26-000950). This amendment is being filed solely to clarify the exact vesting terms of RSU's. |
|